Details for 2018743314

Up to date per 03.04.2026

Actions

Title / Product Name

SYNTHESE VON OMECAMTIV MECARBIL

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018743314

EP Publication Number

3645518

E-Number

1393843

Language

PCT Number

US18040176

Publication Date

06.05.2020 A

19.05.2021 B1

Registration Date

19.05.2021

AT Publication Date

15.06.2021

Application Date

29.06.2018

Registration Number

Priorities

30.06.2017

201762527174 P

30.04.2018

201862664363 P

IPC

C07D 295/205 20060101AFI20190104BHEP

Maximum Duration of Protection

29.06.2038

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks, California 91320-1799US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

CAILLE, Sebastien11521 Gentlewood Drive Moorpark CA 93021US

QUASDORF, Kyle555 Laurie Lane B8 Thousand Oaks CA 91360US

ROOSEN, Philipp1710 Camino Olmo A Thousand Oaks CA 91320US

SHI, Xianqing477 Fallbrook Avenue Newbury Park CA 91320US

COSBIE, Andrew2486 Scoter Avenue Ventura CA 93003US

WANG, Fang149 Parkside Drive Simi Valley CA 93065US

WU, Zufan668 Ash Meadow Drive Walnut CA 91789US

NEERGUNDA, Archana3112 Anasazi Way Simi Valley CA 93063US

QUAN, Bin, Peter5220 Premiere Hills Circle 226 Woodland CA 91364US

GUAN, Lianxiu2145 Euclid Avenue Camarillo CA 93010US

Information about Fees